Abstract:Abstract The development of efficient aggregation‐induced emission (AIE) active probes is crucial for disease diagnosis, particularly for tumors and cardiovascular diseases. Current AIE‐active probes primarily focus on improving their water solubility to resist aggregation, thereby achieving an initial fluorescence‐off state. However, the complex biological environment can cause undesirable aggregation, resulting in false signals. To address this issue, we have ingeniously introduced an azo group into the AIE luminogen (AIEgen), developing a reductase‐activated AIE probe, Azo‐quinoline‐malononitrile (QM)‐PN, for imaging hypoxic environments. In this probe, the azo group promotes intramolecular motion through rapid E / Z isomerization, causing the excited state energy to dissipate via non‐radiative decay, thus turning off the initial fluorescence. In the presence of reductase, Azo‐QM‐PN is reduced and cleaved to produce the hydrophobic AIEgen NH 2 ‐QM‐PN, which subsequently aggregates and generates an in situ AIE signal, thereby imaging the hypoxic environment with reductase. Encapsulation of Azo‐QM‐PN with DSPE‐PEG 2000 results in the formation of the nanoprobe Azo‐QM‐PN NPs, which can effectively penetrate cell membranes, specifically illuminate tumor cells, monitor fluctuations in azo reductase levels, and deeply penetrate and image multicellular tumor spheroids, demonstrating potential for hypoxic tumor imaging. Additionally, the nanoprobe Azo‐QM‐PN NPs can selectively image hypoxic atherosclerotic plaque tissues, showing potential for detecting atherosclerosis. Therefore, in this study, we successfully developed an enzyme‐activated AIE probe for imaging hypoxic environments, laying the foundation for further clinical applications.

Supramolecular fluorescence nanoprobe loaded with azobenzene for the detection of azoreductase: Selective light-up of hypoxic cells

A novel BODIPY-based reductant-sensitive near-infrared fluorescent probe for real-time reporting azoreductase-triggered release

An activatable azophenyl fluorescent probe for hypoxic fluorescence imaging in living cells

Highly Selective Imaging of Lysosomal Azoreductase under Hypoxia Using Ph-Regulated and Target-Activated Fluorescent Nanoprobes

An azo substituted quinoline‐malononitrile enzyme‐activable aggregation‐induced emission nanoprobe for hypoxia imaging

Nitroreductase Detection and Hypoxic Tumor Cell Imaging by a Designed Sensitive and Selective Fluorescent Probe, 7-[(5-Nitrofuran-2-yl)methoxy]-3h-phenoxazin-3-one.

Hypoxia-Responsive Molecular Probe Lighted up by Peptide Self-Assembly for Cancer Cell Imaging

A Novel Long-Wavelength Off-on Fluorescence Probe for Nitroreductase Analysis and Hypoxia Imaging.

A fluorescent turn-on probe for visualizing lysosomes in hypoxic tumor cells.

A ZIF-90 Nanoplatform Loaded with an Enzyme-Responsive Organic Small-Molecule Probe for Imaging the Hypoxia Status of Tumor Cells.

Near-Infrared Fluorescent Probes for Hypoxia Detection via Joint Regulated Enzymes: Design, Synthesis, and Application in Living Cells and Mice.

Small-molecule Probes for Fluorescent Detection of Cellular Hypoxia-Related Nitroreductase

Efficient Two-Photon Fluorescent Probe for Nitroreductase Detection and Hypoxia Imaging in Tumor Cells and Tissues

A near-infrared multifunctional fluorescent probe for hypoxia monitoring and tumor-targeted therapy

A new prodrug-derived ratiometric fluorescent probe for hypoxia: high selectivity of nitroreductase and imaging in tumor cell.

A cyanine-derived “turn-on” fluorescent probe for imaging nitroreductase in hypoxic tumor cells

Development of Azo‐Based Fluorescent Probes to Detect Different Levels of Hypoxia

Azoreductase and Target Simultaneously Activated Fluorescent Monitoring for Cytochrome C Release under Hypoxia

A Highly Sensitive Long-Wavelength Fluorescence Probe for Nitroreductase and Hypoxia: Selective Detection and Quantification.

A dendrimer-functionalized turn-on fluorescence probe based on enzyme-activated debonding feature of azobenzene linkage

Novel Near‐Infrared Fluorescent Nanoprobe Synthesized by the RAFT‐Mediated PISA Strategy for Hypoxia‐Triggered Tumor Imaging and Azoreductase‐Responsive Drug Release